Gene therapy for weight loss: Can one shot replace lifelong GLP-1 drugs?

US biotech firm Fractyl Health is developing Rejuva, an experimental gene therapy that may mimic GLP-1 drugs for years after ...

The next frontier in weight-loss drugs: one-time gene therapy

Fractyl Health is developing a shot that would program the body to make more of the GLP-1 hormone naturally, a risky bet that it can provide a longer-lasting benefit than blockbuster weight-loss drugs ...
Benzinga.com

STAT+: Verve gene-editing therapy lowers cholesterol without serious side effects in early study

Verve Therapeutics said initial data show that its investigational gene-editing therapy lowered cholesterol without inducing serious side effects, a positive step for the company after it paused ...

Intellia gets FDA nod to resume one gene therapy trial after safety pause

By Kamal Choudhury Jan 27 (Reuters) - Intellia Therapeutics said on Tuesday that the U.S. drug regulator has lifted a clinical hold on one of its late-stage gene therapy trials, allowing the company ...
Medical Xpress

Breakthrough gene therapy alleviates Dravet syndrome symptoms in mice without side effects

"Our goal is to be very precise, where we can deliver just the gene that's missing and really target the circuit. Because of that, it can be much safer, more effective, and significantly reduce side ...
TCTMD

CRISPR-Cas9 Gene-Editing Therapy Shows Early Promise for Dyslipidemia

NEW ORLEANS, LA—An investigational CRISPR-Cas9 gene-editing therapy that targets angiopoietin-like protein 3 (ANGPTL3), which has a role in regulating lipid metabolism, appears to safely lower levels ...